N/A
N=215
Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation
Contraception Behavior
Bottom Line
View on ClinicalTrials.gov: NCT00540046 ↗Enrolled (actual)
215
Serious AEs
0.0%
Results posted
Jan 2015
Primary outcome: Primary: Use of IUD — 58; 25 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Copper T 380A IUD (Device)
- Age
- Pediatric, Adult, Older Adult · 16+ yrs
- Sex
- Female
- Sponsor
- NYU Langone Health
- Primary completion
- Feb 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Use of IUD |
58; 25 | — |
| SECONDARY Expulsion |
3.1; 0 | — |
Summary
The purpose of this study is to compare delayed vs. immediate insertion of the Copper T 380 IUD after termination of pregnancy after 12 weeks.
Eligibility Criteria
Inclusion Criteria
- women 16 years of age and older
- intrauterine pregnancy > 14 weeks gestation
- desires termination of pregnancy
- desires IUD for contraception
- ability to give informed consent
- no contraindication for D+E
Exclusion Criteria
- unable to give informed consent
- less than 16 years of age
- congenital or acquired uterine anomaly including fibroids if they distort the uterine cavity
- acute pelvic inflammatory disease (PID)
- known or suspected uterine or cervical neoplasia or unresolved abnormal PAP smear
- untreated acute cervicitis or vaginitis, until infection treated/controlled
- confirmed Chlamydia trachomatis or Neisseria gonorrhea infection in the previous 90 days
- acute liver disease or liver tumor (benign or malignant)
- woman or partner currently with multiple sexual partners
- history of Wilson's disease
- hypersensitivity to any component of Copper T IUD
Data sourced from ClinicalTrials.gov (NCT00540046). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.